Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053)
Clinical trial NCT04634877 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04634877
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-10
- Primary completion
- 2026-09-15
- Enrollment
- 990
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.